C12Y 304/21076
Myeloblastin
Official title: Myeloblastin (3.4.21.76)
C12Y304/21076 (Myeloblastin) appears on 1 US grants and 6 published applications in this corpus.
Search patents in C12Y- Granted patents
- 1
- Published applications
- 6
- Assignees
- 5
- Inventors
- 17
- Latest grant
- 19 Jan 1993
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 1 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 1 |
| 2024 | 0 | 0 |
| 2025 | 0 | 0 |
| 2026 | 0 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Nicotinamide adenine dinucleotide devices and compositions and methods for making the same27 Aug 2026US 2026/0250695 A1Bio Capital Holdings, LLC
- Pharmaceutical compositions comprising protein complexes13 Aug 2026US 2026/0232818 A1Onchilles Pharma, Inc.
- Protein devices and compositions and methods for making the same30 Jul 2026US 2026/0218214 A1Bio Capital Holdings, LLC
- Glycoengineered polypeptides targeting anti-neutrophil autoantibodies and uses thereof26 Feb 2026US 2026/0055211 A1GlycoEra AG
- Methods for extracting neutrophil serine proteases and treating dipeptidyl peptidase 1-mediated conditions5 Oct 2023US 2023/0310453 A1
Most cited
By later US patents